In January 2020, Deer & Co purchased a new office building for $300. The office building has a physical life of 40 years, after which it will have no salvage value, but Deer & Co expects to use it for only 20 years, at which point it will still have a value of $100. Deer & Co accounts for such assets using the double (or 200%) declining balance method. All entries were correctly made in 2020, however no entry was made regarding this building in 2021.

If entries regarding this building had been properly recorded in fiscal year 2021, what would be the reported amounts (not just the effect) for:

a) Total assets as of December 31, 2021?

b) Total shareholders equity as of December 31, 2021?

Income Statement

Balance Sheet and SE

(") rroint atributavie to common snarenoiders See accompanying notes to Consolidated Financial Statements Consolidated Financial Position at December 31 (Dollars in millions) \begin{tabular}{ll} 2021 & 2020 \\ \hline \end{tabular} Assets Current assets: Cash and cash equivalents Receivables - trade and other Receivables - finance Prepaid expenses and other current assets Inventories Total current assets Property, plant and equipment - net Long-term receivables - trade and other Long-term receivables - finance Deferred income taxes Intangible assets Goodwill Other assets Total assets Liabilities Current liabilities: Short-term borrowings: Machinery, Energy \& Transportation Financial Products Accounts payable Accrued expenses Accrued wages, salaries and employee benefits Customer advances Dividends payable Other current liabilities $9,2549,352 Long-term debt due within one year: Machinery, Energy \& Transportation Financial Products Total current liabilities Long-term debt due after one year: Machinery, Energy \& Transportation Financial Products Liability for postemployment benefits Other liabilities Total liabilities Commitments and contingencies (Notes 21 and 22) \begin{tabular}{rr} 45 & 1,420 \\ 6,307 & 7,729 \\ \hline 29,847 & 25,717 \end{tabular} Shareholders' equity Common stock of $1.00 par value: Authorized shares: 2,000,000,000 Issued shares: (2021 and 2020-814,894,624 shares) at paid-in amount Treasury stock: (2021 - 279,006,573 shares; and 2020 269,590,777 shares) at cost Profit employed in the business (*) Accumulated other comprehensive income (loss) Noncontrolling interests Total shareholders' equity Total liabilities and shareholders' equity \begin{tabular}{cc} \hline \hline(27,643) & (25,178) \\ 39,282 & 35,167 \\ (1,553) & (888) \\ \hline 32 & 47 \\ \hline 16,516 & 15,378 \\ \hline$82.793 & $78.324 \\ \hline \end{tabular} See accompanying notes to Consolidated Financial Statements